Welcome to our dedicated page for Mueller Inds SEC filings (Ticker: MLI), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Copper prices move daily; Mueller Industries鈥� profits move with them. If you鈥檝e ever sifted through a 300-page annual report just to find how tubing, brass rod, and HVAC components performed, you know the challenge. Mueller Industries SEC filings explained simply matters because each segment鈥擯iping Systems, Industrial Metals, and Climate鈥攃arries its own risks, environmental notes, and margin drivers.
Stock Titan solves that problem in three steps. First, we stream every document from EDGAR the moment it posts鈥�10-K, 10-Q, 8-K, even the Mueller Industries insider trading Form 4 transactions. Second, our AI instantly extracts the numbers and narratives you search for: copper hedging tactics, segment EBIT, pending remediation costs. Third, plain-language summaries turn accounting jargon into clear insights, so understanding Mueller Industries SEC documents with AI becomes part of your routine, not a weekend project.
Looking for specific answers? You鈥檒l find them here:
- Mueller Industries quarterly earnings report 10-Q filing with side-by-side trend charts
- Mueller Industries annual report 10-K simplified to highlight raw-material sensitivity
- Mueller Industries 8-K material events explained when supply contracts or plant outages hit
- Mueller Industries executive stock transactions Form 4 and Mueller Industries Form 4 insider transactions real-time alerts
- Mueller Industries proxy statement executive compensation if you鈥檙e benchmarking management incentives
Use these AI-powered perspectives for Mueller Industries earnings report filing analysis, to monitor segment momentum before copper futures settle, or to track compliance costs across facilities. Decision-ready information鈥攚ithout digging through footnotes.
Mueller Industries, Inc. (NYSE: MLI) filed a Form 8-K dated July 31, 2025 announcing a routine shareholder return action. The Board of Directors declared a regular quarterly cash dividend of $0.25 per common share. The dividend will be paid on September 19, 2025 to shareholders of record at the close of business on September 5, 2025. The disclosure is contained under Item 8.01 (Other Events); no other operational, financial or strategic updates were provided. A copy of the related press release is included as Exhibit 99.1. No financial statements or pro-forma information accompanied the filing.
Mueller Industries (MLI) 鈥� Form 4 filed 07/31/2025
Chief Manufacturing Officer Steffen Sigloch reported two non-derivative transactions on 07/30/2025:
- Code A grant: 44,000 common shares acquired at $0.00. The filing states these shares "will vest on 7/30/2025." Direct ownership immediately after the grant stood at 164,375 shares.
- Code F disposition: 45,217 shares disposed of at $87.72, leaving 119,158 shares held directly.
No derivative securities were reported and no open-market trades occurred. The form was filed by a single reporting person and does not amend an earlier filing.
The activity reflects routine equity award vesting and an offsetting share disposition, resulting in a small net reduction of 1,217 shares in Sigloch鈥檚 direct stake, which remains substantial.
Mueller Industries (MLI) 鈥� Form 4 filed 07/31/2025
Chief Manufacturing Officer Steffen Sigloch reported two non-derivative transactions on 07/30/2025:
- Code A grant: 44,000 common shares acquired at $0.00. The filing states these shares "will vest on 7/30/2025." Direct ownership immediately after the grant stood at 164,375 shares.
- Code F disposition: 45,217 shares disposed of at $87.72, leaving 119,158 shares held directly.
No derivative securities were reported and no open-market trades occurred. The form was filed by a single reporting person and does not amend an earlier filing.
The activity reflects routine equity award vesting and an offsetting share disposition, resulting in a small net reduction of 1,217 shares in Sigloch鈥檚 direct stake, which remains substantial.
Mueller Industries (MLI) 鈥� Form 4 filed 07/31/2025
Chief Manufacturing Officer Steffen Sigloch reported two non-derivative transactions on 07/30/2025:
- Code A grant: 44,000 common shares acquired at $0.00. The filing states these shares "will vest on 7/30/2025." Direct ownership immediately after the grant stood at 164,375 shares.
- Code F disposition: 45,217 shares disposed of at $87.72, leaving 119,158 shares held directly.
No derivative securities were reported and no open-market trades occurred. The form was filed by a single reporting person and does not amend an earlier filing.
The activity reflects routine equity award vesting and an offsetting share disposition, resulting in a small net reduction of 1,217 shares in Sigloch鈥檚 direct stake, which remains substantial.
Mueller Industries (MLI) 鈥� Form 4 filed 07/31/2025
Chief Manufacturing Officer Steffen Sigloch reported two non-derivative transactions on 07/30/2025:
- Code A grant: 44,000 common shares acquired at $0.00. The filing states these shares "will vest on 7/30/2025." Direct ownership immediately after the grant stood at 164,375 shares.
- Code F disposition: 45,217 shares disposed of at $87.72, leaving 119,158 shares held directly.
No derivative securities were reported and no open-market trades occurred. The form was filed by a single reporting person and does not amend an earlier filing.
The activity reflects routine equity award vesting and an offsetting share disposition, resulting in a small net reduction of 1,217 shares in Sigloch鈥檚 direct stake, which remains substantial.
The Vanguard Group filed Amendment No. 12 to Schedule 13G for Myriad Genetics, Inc. (MYGN) covering the period ended 30 Jun 2025.
- Beneficial ownership: 9,257,493 common shares, representing 10.04 % of outstanding stock.
- Voting power: 0 shares sole; 145,939 shares shared.
- Dispositive power: 9,003,551 shares sole; 253,942 shares shared.
- Filed under Rule 13d-1(b) as an investment adviser (IA); the holding is reported as passive and in the ordinary course of business.
- Crossing the 10 % threshold designates Vanguard as a 10 % beneficial owner, increasing disclosure and potential Section 16 obligations.
The filing signals continued, sizable institutional ownership but does not indicate any intent to influence control. Certification signed by Ashley Grim, Head of Global Fund Administration, on 29 Jul 2025.
On 07/21/2025, Rohit Grover, President, International of The Hershey Company (HSY), sold 1,334 common shares at an average price of $180 per share. The sale was made under a Rule 10b5-1 trading plan adopted on 02/25/2025. After the transaction, Grover directly owns 38,068 HSY shares.
No derivative securities were reported and there were no accompanying acquisitions. The disposition represents roughly 3.4% of Grover鈥檚 prior direct holdings and is modest relative to his remaining stake. While the filing is routine and does not reflect company fundamentals, investors often monitor insider activity as a sentiment gauge.
Match Group, Inc. (MTCH) 鈥� Form 4 insider transaction
Director Glenn H. Schiffman reported one transaction dated 30 June 2025 under the company鈥檚 2020 Deferred Compensation Plan for Non-Employee Directors. The filing shows an acquisition of 486 share units of Match Group common stock at a reference price of $30.89 per unit. Following the credit, Mr. Schiffman鈥檚 aggregate beneficial ownership stands at 42,983 shares, comprising 37,933 directly-held shares and 5,050 deferred share units.
The transaction was coded 鈥淎鈥� (acquisition) and executed automatically through the deferred compensation plan, not an open-market purchase. No derivative securities were reported. The ownership form is direct.
Given Match Group鈥檚 ~280 million shares outstanding, the incremental 486 units represent <0.0002% of total shares and are therefore immaterial to the company鈥檚 capital structure. However, continued share accumulation by a board member may be interpreted by some investors as a sign of ongoing alignment with shareholder interests.
Hims & Hers Health, Inc. (HIMS) 鈥� Form 4 insider transaction
Chief Legal Officer Soleil Boughton filed a Form 4 reporting the sale of 2,572 Class A common shares on 30 Jun 2025 under a previously established Rule 10b5-1 trading plan adopted 28 Aug 2024. The shares were sold at a stated price of $50.50 each (transaction code 鈥淪鈥�), reducing Boughton鈥檚 directly held position to 160,737 shares. No derivative securities were involved and no additional acquisitions were reported.
The transaction represents roughly 1.6 % of the officer鈥檚 post-transaction holdings and generated proceeds of approximately $129 k. Because the sale was executed pursuant to a 10b5-1 plan, it is generally viewed as pre-scheduled rather than opportunistic. No other executives or directors were listed on this filing.
From a governance perspective, the filing signals routine portfolio diversification rather than a material change in insider sentiment. Investors may monitor future filings for patterns or larger-scale disposals, but this single, modest sale is unlikely to alter the fundamental investment thesis for HIMS.
FAQ
What is the current stock price of Mueller Inds (MLI)?
What is the market cap of Mueller Inds (MLI)?
What are the core business segments of Mueller Industries Inc?
What types of products does the company manufacture?
How does Mueller Industries generate revenue?
Which industries benefit from the company鈥檚 products?
What distinguishes Mueller Industries in a competitive market?
What role does the climate segment play in the company's operations?
How does the industrial metals segment support OEM applications?
Where does Mueller Industries operate globally?
